ClinicalTrials.gov Identifier: NCT00477113
Mount Sinai Hospital
490 Blue Hills Ave
Hartford, CT 06112
The purpose of this study is to determine the incidence and pattern of serious infections, malignancies, and other serious adverse events in patients with multiple sclerosis (MS) treated with TYSABRI®.
Status This Study is ongoing, but currently closed to enrollment.
Principal Investigator Peter B. Wade, MD
Contact Kayla Olson, Research Coordinator
Phone (860) 714-2149